était en salle de naissance dans 48,4 % (15/31) des cas en 2014 (groupe « Avant ») et dans 62, pp.5-15 ,
nouveau-nés avant la mise en place du protocole (soit chez 6,4 % des nouveau-nés traités par surfactant) et chez 8 nouveau-nés après la mise en place du protocole (soit chez 33,3 % des nouveau-nés traités par surfactant), p.15 ,
Leur utilisation ne fait pas l'objet de recommandations (15) mais est indiquée dans la prise en charge des enfants évoluant vers une DBP d ,
Epidemiology and causes of preterm birth, The Lancet, vol.371, issue.9606, pp.75-84, 2008. ,
DOI : 10.1016/S0140-6736(08)60074-4
Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.4, pp.1-15 ,
DOI : 10.1016/j.jgyn.2012.04.014
URL : https://hal.archives-ouvertes.fr/inserm-00857949
Survival and Morbidity of Preterm Children Born at 22 Through 34 Weeks??? Gestation in France in 2011, JAMA Pediatrics, vol.169, issue.3, pp.230-238, 2015. ,
DOI : 10.1001/jamapediatrics.2014.3351
URL : https://hal.archives-ouvertes.fr/hal-01258705
Changes in Neonatology: Comparison of Two Cohorts of Very Preterm Infants (Gestational Age <32 Weeks): The Project on Preterm and Small for Gestational Age Infants 1983 and The Leiden Follow-Up Project on Prematurity 1996-1997, PEDIATRICS, vol.115, issue.2, pp.396-405, 2005. ,
DOI : 10.1542/peds.2004-1497
Lung growth and development. Early Hum Dev, pp.789-94, 2007. ,
Available from: http://epar.iplesp.upmc.fr/site_respirare/index Human lung growth in late gestation and in the neonate, Am Rev Respir Dis, vol.129, issue.4, pp.607-620, 1984. ,
Early developmental origins of impaired lung structure and function. Early Hum Dev, pp.763-71, 2005. ,
Lung diseases in children associated with inherited disorders of surfactant metabolism], Rev Pneumol Clin, 2013. ,
Réanimation et soins intensifs en néonatalogie ,
Le surfactant pulmonaire: de la physiologie à la thérapeutique. mMédecine/sciences, pp.277-87, 1993. ,
Corticothérapie anténatale : prévention de la maladie des membranes hyalines et des complications de la prématurité, Doss CNHIM, 1999. ,
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update, Neonatology, vol.111, issue.2, pp.107-132, 2017. ,
DOI : 10.1159/000448985
Néonatalogie: bases scientifiques, 2017. ,
Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants, European Respiratory Journal, vol.14, issue.1, pp.155-164, 1999. ,
DOI : 10.1034/j.1399-3003.1999.14a26.x
Management of respiratory distress syndrome: an update. Respir Care, 2003. ,
Risk factors for respiratory distress syndrome in the newborn. A multicenter Italian survey. Study Group for Lung Maturity of the Italian Society of Perinatal Medicine, Acta Obstet Gynecol Scand, 1993. ,
The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics, 1995. ,
Morbidity and mortality patterns in small-for-gestational age infants born preterm, The Journal of Maternal-Fetal & Neonatal Medicine, vol.81, issue.10, pp.153-160, 2012. ,
DOI : 10.1016/j.earlhumdev.2004.10.003
Population based study on the outcome of small for gestational age newborns. Arch Dis Child Fetal Neonatal Ed, 2005. ,
Respiratory distress syndrome in infants with impaired intrauterine growth, Acta Paediatrica, vol.45, issue.10, 1992. ,
DOI : 10.1007/BF01957761
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev. 2017, vol.213, p.4454 ,
Pulmonary disease following respirator therapy of hyalinemembrane disease. Bronchopulmonary dysplasia, N Engl J Med Feb, vol.16276, issue.7, pp.357-68, 1967. ,
The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations]. Arch Pediatr Organe Off Soc Francaise Pediatr, pp.1480-1487, 2010. ,
Adult respiratory sequelae of premature birth]. Rev Mal Respir, pp.1329-1368, 2011. ,
Prevention of bronchopulmonary dysplasia: current strategies, Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr, vol.19, issue.8, pp.841-51, 2017. ,
La nouvelle dysplasie broncho-pulmonaire: physiopathologie, traitement, pr??vention, Archives de P??diatrie, vol.22, issue.5, 2015. ,
DOI : 10.1016/S0929-693X(15)30052-X
Altered lung development in bronchopulmonary dysplasia, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.8, issue.Pt 1, pp.158-67, 2014. ,
DOI : 10.1371/journal.pone.0078326
Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function. Arch Dis Child Fetal Neonatal Ed, pp.459-464, 2007. ,
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia, PEDIATRICS, vol.116, issue.6, pp.1353-60, 2005. ,
DOI : 10.1542/peds.2005-0249
Safety, Reliability and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia, Journal of Perinatology, vol.790, issue.6, pp.451-457, 2003. ,
DOI : 10.1136/fn.79.1.F64
Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates, PEDIATRICS, vol.114, issue.5, pp.1305-1316, 2004. ,
DOI : 10.1542/peds.2004-0204
Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia, Pediatrics, 1996. ,
Ventilation in Extremely Preterm Infants and Respiratory Function at 8 Years, N Engl J Med. 2017, vol.27377, issue.4, pp.329-366 ,
Chorioamnionitis, Surfactant, and Lung Disease in Very Low Birth??Weight??Infants, The Journal of Pediatrics, vol.156, issue.1, pp.3-4, 2010. ,
DOI : 10.1016/j.jpeds.2009.08.009
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study, BMJ Open, vol.7, issue.7, p.15232, 2017. ,
DOI : 10.1136/bmjopen-2016-015232
URL : https://doi.org/10.1136/bmjopen-2016-015232
Bronchopulmonary dysplasia in very and extremely low birth weight infants -analysis of selected risk factors. Pol Merkur Lek Organ Pol Tow Lek, Feb, vol.2042, issue.248, pp.71-76, 2017. ,
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev, p.4454, 2006. ,
Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants, American Journal of Respiratory and Critical Care Medicine, vol.97, issue.3 ,
DOI : 10.1038/jp.2016.100
A comprehensive approach to the prevention of bronchopulmonary dysplasia, Pediatric Pulmonology, vol.19, issue.12, pp.1153-65, 2011. ,
DOI : 10.1038/sj.jp.7200205
Réanimation du nouveau-né en salle de naissance. Sauramps medical, 2017. ,
Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial, The Lancet, vol.387, issue.10030, pp.1827-1863, 2016. ,
DOI : 10.1016/S0140-6736(16)00202-6
URL : https://hal.archives-ouvertes.fr/hal-01278609
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age, JAMA, vol.317, issue.13, pp.1329-1366, 201704. ,
DOI : 10.1001/jama.2017.2692
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia, New England Journal of Medicine, vol.373, issue.16, pp.1497-506, 2015. ,
DOI : 10.1056/NEJMoa1501917
Inhaled nitric oxide for respiratory failure in preterm infants, Cochrane Database Syst Rev. 2017, vol.1, pp.3-000509 ,
Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.354, issue.20, pp.2112-2133, 2006. ,
DOI : 10.1056/NEJMoa054065
Vitamin A supplementation to prevent mortality and short-and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev, p.501, 2016. ,
Early Postnatal Additional High-Dose Oral Vitamin A Supplementation versus Placebo for 28 Days for Preventing Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants, Neonatology, vol.105, issue.3, pp.182-190, 2014. ,
DOI : 10.1159/000357212
Azithromycin and Other Macrolides for Prevention of Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis, Neonatology, vol.106, issue.4, pp.337-384, 2014. ,
DOI : 10.1159/000363493
Impact of Nutrition on Bronchopulmonary Dysplasia, Clinics in Perinatology, vol.42, issue.4, pp.797-806, 2015. ,
DOI : 10.1016/j.clp.2015.08.007
Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants, Cochrane Database Syst Rev, issue.12, p.503, 2014. ,
Committee on Fetus and Newborn American Academy of Pediatrics. Patent Ductus Arteriosus in Preterm Infants, Pediatrics, vol.137, issue.1, 2016. ,
Devenir respiratoire à long terme des prématurés: implications pour le suivi. Httpwwwem-Premiumcomdatarevues0929693Xv22i5sS1S0929693X15300531, 2015. ,
DOI : 10.1016/s0929-693x(15)30053-1
Respiratory outcome of bronchopulmonary dysplasia in school-age children]. Arch Pediatr Organe Off Soc Francaise Pediatr, pp.325-357, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01274307
Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome, Cochrane Database Syst Rev, vol.8, p.144, 2015. ,
A Multicenter, Randomized, Controlled Trial of Lucinactant Versus Poractant Alfa Among Very Premature Infants at High Risk for Respiratory Distress Syndrome, PEDIATRICS, vol.115, issue.4, 2005. ,
DOI : 10.1542/peds.2004-2231
Acute and Sustained Effects of Lucinactant Versus Poractant-?? on Pulmonary Gas Exchange and Mechanics in Premature Lambs With Respiratory Distress Syndrome, PEDIATRICS, vol.117, issue.2, pp.295-303, 2006. ,
DOI : 10.1542/peds.2005-0378
Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs, Pediatric Pulmonology, vol.12, issue.7, pp.929-967 ,
DOI : 10.1542/peds.2011-1395
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev, p.1456, 2012. ,
Continuous Positive Airway Pressure Failure in Preterm Infants: Incidence, Predictors and Consequences, Neonatology, vol.63, issue.1, pp.8-14, 2013. ,
DOI : 10.1136/adc.63.1.10
Incidence and Outcome of CPAP Failure in Preterm Infants, PEDIATRICS, vol.138, issue.1, 2016. ,
DOI : 10.1542/peds.2015-3985
Noninvasive Ventilation With vs Without Early Surfactant to Prevent Chronic Lung Disease in Preterm Infants, JAMA Pediatrics, vol.169, issue.8, pp.731-740, 2015. ,
DOI : 10.1001/jamapediatrics.2015.0510
Early CPAP versus surfactant in extremely preterm infants, N Engl J Med, vol.362, issue.21, pp.1970-1979, 2010. ,
Risk factors for intubation???surfactant???extubation (INSURE) failure and multiple INSURE strategy in preterm infants, Early Human Development, vol.88, issue.1, pp.3-4 ,
DOI : 10.1016/j.earlhumdev.2011.12.019
Modalit??s non invasives d'instillation du surfactant exog??ne, Archives de P??diatrie, vol.22, issue.5, p.986260, 2015. ,
DOI : 10.1016/S0929-693X(15)30051-8
Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome, New England Journal of Medicine, vol.331, issue.16, pp.1051-1056, 1994. ,
DOI : 10.1056/NEJM199410203311603
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome, Cochrane Database Syst Rev, issue.3, p.3063, 2004. ,
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev, p.3063, 2007. ,
DOI : 10.1002/14651858.cd003063
Implementation of surfactant treatment during continuous positive airway pressure, Journal of Perinatology, vol.89, issue.7, pp.422-429, 2007. ,
DOI : 10.1203/01.PDR.0000025341.25481.42
Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge ,
Surfactant Administration by Transient Intubation in Infants 29 to 35 Weeks' Gestation with Respiratory Distress Syndrome Decreases the Likelihood of Later Mechanical Ventilation: A Randomized Controlled Trial, Journal of Perinatology, vol.53, issue.11, pp.703-711, 2005. ,
DOI : 10.1164/ajrccm.163.7.2011060
Prophylactic or Early Selective Surfactant Combined With nCPAP in Very Preterm Infants, PEDIATRICS, vol.125, issue.6, 2010. ,
DOI : 10.1542/peds.2009-2131
Minimallyinvasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed, pp.122-126, 2013. ,
Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial, The Lancet, vol.378, issue.9803, pp.1627-1661, 2011. ,
DOI : 10.1016/S0140-6736(11)60986-0
Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants, JAMA Pediatrics, vol.169, issue.8, pp.723-753, 2015. ,
DOI : 10.1001/jamapediatrics.2015.0504
URL : http://archpedi.jamanetwork.com/data/journals/peds/934251/poi150023.pdf
Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial, PEDIATRICS, vol.131, issue.2, p.2013 ,
DOI : 10.1542/peds.2012-0603
URL : http://pediatrics.aappublications.org/content/pediatrics/131/2/e502.full.pdf
Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed, pp.17-23, 2017. ,
Nebulizing poractant alfa versus conventional instillation: Ultrastructural appearance and preservation of surface activity, Pediatric Pulmonology, vol.10, issue.4, pp.348-56 ,
DOI : 10.1089/jamp.2007.0662
Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial, Am J Perinatol, vol.30, issue.3, pp.201-207, 2013. ,
Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network, PEDIATRICS, vol.126, issue.3, 2010. ,
DOI : 10.1542/peds.2009-2959
Sepsis as a risk factor for neonatal morbidity in extremely preterm infants, Acta Paediatrica, vol.16, issue.11, pp.1070-1076, 1992. ,
DOI : 10.1097/00006454-199704000-00009
Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study, BMC Pediatrics, vol.2013, issue.1, p.155, 2014. ,
DOI : 10.1155/2013/892974
Risk Factors of the Failure of Surfactant Treatment by Transient Intubation during Nasal Continuous Positive Airway Pressure in Preterm Infants, American Journal of Perinatology, vol.25, issue.10, pp.647-52, 2008. ,
DOI : 10.1055/s-0028-1090590
Is it acceptable in 2014 that three-quarters of newborns are intubated without any sedation in the delivery room?]. Arch Pediatr Organe Off Soc Francaise Pediatr, 2014. ,
Premedication for Nonemergency Endotracheal Intubation in the Neonate, PEDIATRICS, vol.125, issue.3, pp.608-623, 2010. ,
DOI : 10.1542/peds.2009-2863
A national survey on pain management before tracheal intubation in neonates in French type III maternity units]. Arch Pediatr Organe Off Soc Francaise Pediatr, Feb, vol.20, issue.2, pp.123-132, 2013. ,
Ketamine and atropine decrease pain for preterm newborn tracheal intubation in the delivery room: an observational pilot study, Acta Paediatrica, vol.17, issue.12, pp.534-538, 1992. ,
DOI : 10.1097/00003246-198912000-00009
Ketamine is a neurotoxic agent that could adversely affect the brains of preterm babies, Acta Paediatrica, vol.116, issue.12, 1992. ,
DOI : 10.1213/ANE.0b013e3182860fc9
Developmental neurotoxicity of ketamine in pediatric clinical use, Toxicology Letters, vol.220, issue.1, pp.53-60, 2013. ,
DOI : 10.1016/j.toxlet.2013.03.030
Assessment of atropine-sufentanil-atracurium anaesthesia for endotracheal intubation: an observational study in very premature infants, BMC Pediatrics, vol.122, issue.4, p.120, 2014. ,
DOI : 10.1542/peds.2007-2545
URL : https://hal.archives-ouvertes.fr/inserm-00993899
Use of naloxone to minimize extubation failure after premedication for INSURE procedure in preterm neonates, Journal of Neonatal-Perinatal Medicine, vol.123, issue.7, pp.363-70, 2016. ,
DOI : 10.1001/archopht.123.7.991
Sedation and Analgesia to Facilitate Mechanical Ventilation, Clinics in Perinatology, vol.40, issue.3, pp.539-58, 2013. ,
DOI : 10.1016/j.clp.2013.05.005
Are newborns receiving premedication before elective intubation? J Perinatol Off J Calif Perinat Assoc, pp.286-295, 2006. ,
DOI : 10.1038/sj.jp.7211499
URL : http://www.nature.com/jp/journal/v26/n5/pdf/7211499a.pdf
Sedation during Minimal Invasive Surfactant Therapy in Preterm Infants, Neonatology, vol.109, issue.4, pp.308-321, 2016. ,
DOI : 10.1159/000443823
Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants, Global Pediatric Health, vol.154, pp.2333794-17696683, 2017. ,
DOI : 10.1038/pr.2014.66
European perspective on less invasive surfactant administration???a survey, European Journal of Pediatrics, vol.19, issue.2, pp.147-54, 2017. ,
DOI : 10.1111/j.1460-9592.2010.03330.x
Less Invasive Surfactant Administration (LISA) ??? Ways to deliver surfactant in spontaneously breathing infants, Early Human Development, vol.89, issue.11, pp.875-80, 2013. ,
DOI : 10.1016/j.earlhumdev.2013.08.023